NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 83 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $52,000 | – | 27,486 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 2,291,133 | $1,166,187 | 1.01% |
Privium Fund Management (UK) Ltd | 117,200 | $59,655 | 0.04% |
Redmile Group, LLC | 1,850,566 | $941,938 | 0.04% |
Baker Brothers Advisors | 3,821,740 | $1,945,266 | 0.01% |
Kynam Capital Management, LP | 120,764 | $61,469 | 0.01% |
Sio Capital Management, LLC | 38,312 | $19,501 | 0.01% |
SIMON QUICK ADVISORS, LLC | 46,856 | $23,850 | 0.00% |
Tri Locum Partners LP | 10,248 | $5,000 | 0.00% |
Endurance Wealth Management, Inc. | 20,000 | $10 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $38,175 | 0.00% |